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Abstract Unrecognized myocardial infarction (MI) car-
ries a poor prognosis in the general population, but its
prognostic value is less clear in high-risk patients. We
sought to determine whether Q waves on electrocardio-
gram (ECG), suggestive of unrecognized MI, predict car-
diovascular events in patients with stable coronary artery
disease (CAD), but without a prior history of MI. We
studied 462 patients enrolled in the Heart and Soul Study
with stable CAD but without a prior history of MI. All
patients had baseline ECGs. The baseline prevalence of
unrecognized myocardial infarction was 36%. After a mean
of 6.3 years of follow-up, there were a total of 141 car-
diovascular events. The presence of Q waves in any ECG
lead territory predicted cardiovascular events before
(unadjusted HR 1.41, 95% CI 1.01–1.97) and after
adjustment for demographics, medical history, diastolic
function, and ejection fraction (HR 1.55, 95% CI
1.06–2.26). This association was partly attenuated after
adjustment for the presence of inducible ischemia at
baseline (HR 1.43, 95% CI 0.96–2.12). When speciﬁc
territories were analyzed separately, Q waves in anterior
leads were predictive of cardiovascular events in both
unadjusted and adjusted models (adjusted HR 1.85, 95% CI
1.14–3.00), and this association was partly attenuated after
adjustment for inducible ischemia. In conclusion, in
patients with CAD but no history of prior MI, the presence
of any Q waves or anterior Q waves alone is independently
predictive of adverse cardiovascular events.
Keywords Q wave  Unrecognized myocardial
infarction  Electrocardiogram  Coronary artery disease
Introduction
Unrecognized or ‘‘silent’’ myocardial infarction (MI) is
common, and may account for 20–60% of all MI in
otherwise asymptomatic patients over the age of 45 [1–4].
The diagnosis of unrecognized infarction has traditionally
been deﬁned as the presence of pathologic Q waves on the
electrocardiogram (ECG) of a patient without a clinical
history of MI. The prognostic signiﬁcance of Q waves,
indicative of unrecognized infarction, is similar to clini-
cally recognized infarction in the general population [5].
Only one major study in asymptomatic subjects has sug-
gested that unrecognized infarction may be more benign
than recognized infarction [6]. Unrecognized infarcts are
also at least as likely as recognized infarcts to lead to heart
failure and stroke [7, 8]. Studies have further shown that Q
waves carry an increased risk for impaired functional status
and all-cause mortality, effects which both appear to be
mediated by structural abnormalities suggestive of global
rather than regional cardiac dysfunction [9].
The study of Q waves in unrecognized infarction has
been conducted primarily in the general population.
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DOI 10.1007/s00392-010-0255-2Limited studies of high-risk patients, or those with estab-
lished coronary artery disease (CAD), have suggested that
unrecognized infarction may be less common in women
[10], but the prognostic value of electrocardiographic
detection of unrecognized infarction in patients with CAD
has not been well studied. In contrast to results from the
general population, a signiﬁcant association between
unrecognized Q waves and adverse cardiac outcomes has
not been observed in limited studies of patients with CAD
[11], casting some doubt on the prognostic utility of elec-
trocardiographic detection of infarction in this population.
In light of these ﬁndings, we sought to determine the
prognostic signiﬁcance of Q waves on ECG in a large
population of patients with stable CAD, absent a history of
MI.
Methods
The Heart and Soul Study is a prospective cohort study
investigating the effect of psychosocial factors on cardio-
vascular outcomes in patients with stable CAD. Details of
the study methods have previously been described [12]. A
total of 1,024 patients were enrolled between September
2000 and December 2002. Patients were recruited from
outpatient clinics in the San Francisco Bay Area. All
patients provided written informed consent and the study
protocol was approved by the institutional review boards at
all sites. Eligible participants met at least one of the fol-
lowing criteria: (1) history of MI, (2) angiographic evi-
dence of at least 50% stenosis by area in at least one
coronary artery, (3) evidence of exercise-induced ischemia
by treadmill electrocardiogram or stress nuclear perfusion
imaging, or (4) history of coronary revascularization.
Individuals were excluded from this particular study if they
had any history of MI, deemed themselves unable to walk 1
block, or if they were planning to move out of the local
area within 3 years. Of the 1,024 patients initially enrolled
in the Heart and Soul Study, 462 met these criteria and
were included in the analysis.
All patients underwent baseline electrocardiography at
enrollment. Q waves were determined manually by two
independent and blinded internal medicine physicians.
Using Minnesota Code Criteria [13] each physician clas-
siﬁed Q waves as absent, possible (duration of 30–40 ms),
or probable (duration[40 ms) in any lead of three lead
territories: inferior (leads II, III, and aVF), lateral (leads I,
aVL, V6), or anterior (leads V1–V5). Any discrepancies
were resolved by consensus or (if necessary) by a third
internal medicine physician. Possible and probable Q
waves were pooled together for subsequent analysis.
Allpatientsunderwentcompleterestingtwo-dimensional
echocardiography and Doppler examination using an
Acuson Sequoia ultrasound system (Siemens Medical
Solutions, Mountain View, CA, USA) with a 3.5-MHz
transducer. Standard parasternal short-axis and apical two
and four chamber views were obtained at rest and at peak
exercise to detect the presence or development of left ven-
tricular wall motion abnormalities. End-systolic and end-
diastolic volumes were determined by planimetry. The left
ventricular ejection fraction was calculated as (end diastolic
volume–end systolic volume)/end diastolic volume. Dia-
stolicdysfunctionwasdeﬁnedaspseudonormalorrestrictive
basedonthemitralDopplerinﬂowpattern[14].Regionalleft
ventricular function was assessed with a standard 16-seg-
ment model [15]. Segmental scores were assigned as fol-
lows: normal or hyperkinesis-1; hypokinesis-2; akinesis-3;
dyskinesis-4;andaneurismal-5.Thewallmotionscoreindex
wasderivedasthesumofallscoresdividedbythenumberof
segments visualized.
We assessed the presence of inducible cardiac ischemia
using exercise treadmill testing with stress echocardiogra-
phy [16]. We performed a symptom-limited, graded exer-
cise treadmill test according to a standard Bruce protocol.
Inducible ischemia was deﬁned as the presence of new wall
motion abnormalities at peak exercise that were not present
at rest. The results from stress echocardiography were
interpreted by a single expert cardiologist, who was blinded
to the presence of self-reported angina.
Age, sex, ethnicity, smoking status, and medical history
were determined by self-report. Systolic and diastolic
blood pressures (mm Hg) were measured with the patient
at rest by trained study personnel using a calibrated
sphygmomanometer. Weight and height were measured to
calculate body mass index (kg/m
2). Participants were
instructed to bring their medication bottles to the study
appointment, and study personnel recorded all current
medications using Epocrates Rx (San Mateo, CA, USA).
We conducted annual telephone interviews with partic-
ipants or their proxies regarding recent emergency room
visits, hospitalizations, or death. Medical treatment at fol-
low-up was not recorded. For any reported event, medical
records, death certiﬁcates, and coroner’s reports were
reviewed by two independent and blinded adjudicators. If
the adjudicators agreed on the outcome classiﬁcation, their
classiﬁcation was binding. If they disagreed, a third blinded
adjudicator reviewed the event and determined the out-
come classiﬁcation.
The primary outcome was cardiovascular events, a
composite of all-cause death, nonfatal MI, and stroke.
Nonfatal MI was deﬁned by the American Heart Associa-
tion diagnostic criteria [17]. Stroke was deﬁned as a new
neurological deﬁcit not known to be secondary to brain
trauma, tumor, infection, or other cause [18]. Other out-
comes ascertained included hospitalization for heart fail-
ure, which was deﬁned as a minimum one-night hospital
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123stay for a clinical syndrome comprising at least two of the
following: paroxysmal nocturnal dyspnea, orthopnea, ele-
vated jugular venous pressure, pulmonary rales, third heart
sound, and cardiomegaly or pulmonary edema on chest
radiography [19]. These clinical signs and symptoms must
have represented a clear change from the baseline clinical
status of the participant and must have been accompanied
by either failing cardiac output as determined by peripheral
hypoperfusion (in the absence of other causes such as
sepsis or dehydration) or peripheral or pulmonary edema
requiring intravenous diuretics, inotropes, or vasodilators.
All-cause mortality was determined by review of death
certiﬁcates.
Differences in baseline characteristics were compared
with the use of analysis of variance for continuous
variables and the chi-squared test for dichotomous vari-
ables, as appropriate. Using the Kaplan–Meier technique,
the probability of survival free from cardiovascular
events was plotted against time for the presence of any Q
waves and anterior Q waves. Cox proportional hazards
models were used to examine the association between Q
waves in any ECG territory and cardiovascular events.
Cox models were also used to separately evaluate the
association of Q waves in each of the three ECG terri-
tories with cardiovascular events. Multivariate adjustment
was performed sequentially for age, gender, ethnicity,
past history of smoking, history of congestive heart
failure, and diastolic dysfunction, followed by either left
ventricular ejection fraction or resting wall motion score
and inducible ischemia. These covariates for the multi-
variable models were chosen a priori based on published
associations and biologic plausibility. Covariate selection
was checked by visual inspection of directed acyclic
graphs [20]. From the Cox models, unadjusted and
adjusted hazard ratios (HR) with 95% conﬁdence inter-
vals (CI) were obtained. Participants were censored at
date of ﬁrst event or last contact, whichever came ﬁrst.
Outcome ascertainment was complete in 99% of partici-
pants. Statistical analysis was performed using SAS
software version 9.1 (SAS Institute Inc).
Results
In 462 participants without a history of prior MI, 199 Q
waves were identiﬁed on baseline ECG in 167 participants
(36%). When accounting for the 562 patients excluded
from the study for a history of recognized infarction,
unrecognized infarction accounted for 23% of all infarc-
tions and was present in 16% of all patients enrolled in the
Heart and Soul Study. The regional distribution of the Q
waves was as follows: anterior 136(68%), inferior 9(5%),
and lateral 54(27%).
Compared with participants without Q waves, those with
Q waves in any territory were less likely to have a history
of prior smoking, and somewhat more likely to have a
history of heart failure (Table 1). There were no signiﬁcant
differences between participants with Q waves compared
with those without Q waves with respect to age, gender,
ethnicity, other medical history, medications, or echocar-
diographic measures including left ventricular ejection
fraction, diastolic dysfunction, resting wall motion score,
and inducible ischemia.
During a mean follow-up of 6.3 years, there were 141
non-overlapping cardiovascular events (116 deaths, 14
strokes, 43 nonfatal MIs) (Table 2). The annual event rate
was 4.5% among patients without Q waves, compared with
6.2% among patients with any Q waves (p = 0.05)
(Table 2). No signiﬁcant differences were found between
patients with and without any Q waves with respect to
event rates for all-cause death, nonfatal MI, or stroke alone
(Table 2). Figure 1 demonstrates the survival curve for
freedom from cardiovascular events for the presence of any
Q waves compared with the absence of Q waves.
In the unadjusted Cox model, the presence of Q waves
in any territory was associated with a 41% increase in risk
for adverse cardiovascular events (HR 1.41, p = 0.05; 95%
CI 1.01–1.97) (Table 3). This association remained after
sequential adjustment for age (Model 1), gender, ethnicity,
and history of prior smoking (Model 2), history of heart
failure and diastolic dysfunction (Model 3), and left ven-
tricular ejection fraction (Model 4 adjusted HR 1.55,
p = 0.02, 95% CI 1.06–2.26) (Table 3). When ejection
fraction was replaced by resting wall motion score in the
adjustment model, the association remained signiﬁcant
(Model 5 adjusted HR 1.59, p = 0.02, 95% CI 1.09–2.30)
(Table 3), but it was partly attenuated after subsequent
adjustment for inducible ischemia (Model 6 adjusted HR
1.43, p = 0.08, 95% CI 0.96–2.12) (Table 3). The presence
of Q waves in any territory was not associated with
increased risk for all-cause death in unadjusted (HR 1.37,
p = 0.10, 95% CI 0.95–1.96) or adjusted models (Model 4
adjusted HR 1.38, p = 0.14, 95% CI 0.90–2.10). A non-
signiﬁcant trend toward an association was found in
adjustment model 5 (Model 5 adjusted HR 1.47, p = 0.07,
95% CI 0.97–2.23), which was not present after subsequent
adjustment for inducible ischemia (Model 6 adjusted HR
1.34, p = 0.20, 95% CI 0.86–2.08).
In Cox models analyzing the prognostic relevance of Q
wave territory, participants with lateral Q waves did not
show increased risk for cardiovascular events compared
with those without any Q waves (unadjusted HR 1.19, 95%
CI 0.84–1.70; Model 6 adjusted HR 1.21, 95% CI
0.79–1.86) (Table 4). Participants with inferior Q waves
showed trends toward increased risk for cardiovascular
events compared with those without any Q waves, but these
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123did not reach statistical signiﬁcance and the conﬁdence
intervals were wide with only nine inferior Q waves noted
among participants (Model 6 adjusted HR 2.53, 95% CI
0.70–9.03) (Table 4). Participants with anterior Q waves
showed a statistically signiﬁcant, 80% increased risk for
cardiovascular events compared with those without any Q
waves in the unadjusted model as well as the ﬁrst four
sequential adjustment models (unadjusted HR 1.80, 95%
CI 1.15–2.82; Model 4 adjusted HR 1.85, 95% CI
1.14–3.00) (Table 4). This association was maintained
when resting wall motion score was substituted for ejection
fraction in the adjustment model (Model 5 adjusted HR
1.80, 95% CI 1.11–2.93), and attenuated modestly after
further adjustment for inducible ischemia (Model 6
adjusted HR 1.61, 95% CI 0.95–2.78) (Table 4). Figure 2
demonstrates the survival curve for freedom from cardio-
vascular events for the presence of anterior Q waves
compared with the absence of any Q waves.
Discussion
In patients with stable CAD but without prior history of
MI, we found that the presence of any Q wave on baseline
ECG is independently associated with adverse cardiovas-
cular events including death, nonfatal MI, and stroke. This
association does not appear to be mediated by global
echocardiographic parameters of systolic or diastolic
Table 1 Baseline
characteristics of study
population categorized by
presence or absence of Q waves
Data reported as N (%) or
mean ± standard deviation
Variable No Q waves
(N = 295)
Any Q wave
(N = 167)
P value
Age (years) 67 ± 11 67 ± 10 0.53
Male 240 (81) 127 (76) 0.18
White 175 (59) 88 (53) 0.17
Body mass index (kg/m
2) 28.8 ± 5.2 28.5 ± 5.5 0.59
Current smoking 48 (16) 35 (21) 0.20
Prior smoking 144 (50) 66 (40) 0.05
Hypertension 206 (70) 119 (72) 0.67
History of congestive heart failure 28 (9) 25 (15) 0.07
History of stroke 28 (9) 19 (11) 0.52
History of diabetes 77 (26) 38 (23) 0.42
Revascularization 148 (50) 82 (49) 0.87
Statin use 182 (62) 93 (56) 0.21
Aspirin use 221 (75) 117 (70) 0.26
Beta-blocker use 153 (52) 84 (50) 0.75
Renin-angiotensin inhibitor use 128 (43) 79 (47) 0.42
Systolic blood pressure (mmHg) 133.7 ± 19.4 135.9 ± 21.4 0.27
Diastolic blood pressure (mmHg) 75.0 ± 11.4 76.4 ± 11.8 0.21
Left ventricular ejection fraction 63.8 ± 7.1 63.9 ± 8.2 0.95
Left ventricular mass index (g/m
2) 94.3 ± 24.7 96.8 ± 28.8 0.32
Diastolic dysfunction 25 (10) 18 (13) 0.35
Inducible ischemia 47 (17) 29 (19) 0.65
Resting wall motion score 1.06 ± 0.21 1.07 ± 0.21 0.62
Table 2 Adverse cardiovascular outcomes categorized by presence or absence of Q waves
OUTCOME No Q waves (N = 295) Any Q wave (N = 167) P value for
annual event rate
Total events Annual rate Total events Annual rate
Cardiovascular events (all-cause death,
nonfatal myocardial infarction, or stroke)
82 0.045 59 0.062 0.05
All-cause death 68 0.035 48 0.047 0.17
Nonfatal myocardial infarction 26 0.014 17 0.017 0.56
Stroke 7 0.004 7 0.007 0.25
Congestive heart failure hospitalization 33 0.018 27 0.028 0.11
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123function, but may be mediated in part by inducible cardiac
dysfunction. Our ﬁndings extend the current literature on
unrecognized infarction to a high-risk population in which
this entity has been less well characterized. The results
contrast with observations from prior small studies in this
population, but are in concordance with larger studies in
the general population. We demonstrate that unrecognized
MI is both highly prevalent and prognostically important,
even in a high-risk population under close medical
surveillance. Furthermore, Q waves in anterior territories
alone were associated with increased risk.
The prevalence of unrecognized Q-wave infarction in
this study among patients with CAD but without known
infarction is notably higher (36%) than reported previously
in similar populations (8–12%) [11, 21]. The proportion of
unrecognized Q-wave MI in our study population was 23%
of all MI, which was also notably higher than a previously
reported proportion of 4.3% in a population of women with
CAD [10]. Although estimates of the reported rates of
unrecognized infarction can vary signiﬁcantly depending
on electrocardiographic criteria used for diagnosis [3], our
detection methodology was similar to prior studies in this
population. A more likely explanation for the discrepancy
in prevalence is a greater disease burden in our population
of predominantly male patients. Alternatively, our popu-
lation may have had a higher proportion of Q-wave com-
pared with non-Q-wave MI. Recent studies have shown
that total infarct size and endocardial extent of infarction
correlate best with Q waves on ECG [22, 23], a ﬁnding
which is consistent with the physiologic basis of Q waves
as a reﬂection of the absence of depolarizing currents
within the endocardium [24]. The population in this study
could have suffered larger infarcts involving more endo-
cardium, thereby demonstrating a higher fraction of Q-
wave compared with non-Q-wave infarctions.
One prior study in the general population suggested that
in patients with impaired functional status, global myo-
cardial dysfunction may mediate an association between
Fig. 1 Kaplan–Meier survival
curves showing freedom from
cardiovascular events (p = 0.05
from log rank test)
Table 3 Association of Q waves in any territory with cardiovascular
events (all-cause death, nonfatal myocardial infarction, stroke)
Model Any Q wave HR (95% CI) P value
Unadjusted 1.41 (1.01–1.97) 0.05
Model 1
a 1.39 (0.99–1.94) 0.06
Model 2
b 1.44 (1.03–2.03) 0.04
Model 3
c 1.50 (1.04–2.17) 0.03
Model 4
d 1.55 (1.06–2.26) 0.02
Model 5
e 1.59 (1.09–2.30) 0.02
Model 6
f 1.43 (0.96–2.12) 0.08
a Model 1 = Age
b Model 2 = Model 1 ? gender, ethnicity, prior smoking
c Model 3 = Model 2 ? history of congestive heart failure, diastolic
dysfunction
d Model 4 = Model 3 ? left ventricular ejection fraction
e Model 5 = Model 3 ? wall motion score
f Model 6 = Model 5 ? inducible ischemia
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123unrecognized Q waves and mortality, even in the absence
of regional wall motion abnormalities [9]. In contrast, in
our study adjustment for left ventricular ejection fraction
and diastolic dysfunction did not attenuate the association
between Q waves and adverse cardiovascular events. This
is consistent with a biological mechanism distinct from
global myocardial dysfunction. Adjustment for exercise-
induced, though not resting, segmental wall motion
abnormalities did attenuate the association modestly, sug-
gesting that the prognostic importance of this ECG marker
may act in part through segmental, but not global, dys-
function in patients with CAD.
Our ﬁnding that Q waves in anterior lead territories
predict poor outcomes but not those in inferior or lateral
territories is to our knowledge the ﬁrst demonstration of the
prognostic importance of Q wave location in unrecognized
infarction. This result is consistent with cardiac magnetic
resonance imaging (MRI) data which have shown a strong
correlation between infarct size and Q wave presence only
in anterior territories, and not in lateral or inferior territo-
ries [25]. Therefore, this ﬁnding could be due to a greater
speciﬁcity of Q waves for myocardial scar in anterior ter-
ritories. Alternatively, this result could indicate a greater
clinical impact of segmental wall dysfunction due to scar in
Table 4 Association of Q waves in speciﬁc territories with cardiovascular events (all-cause death, nonfatal myocardial infarction, stroke)
Model Lateral Q waves HR (95% CI) Inferior Q waves HR (95% CI) Anterior Q waves HR (95% CI)
Unadjusted 1.19 (0.84–1.70) 1.80 (0.66–4.86) 1.80 (1.15–2.82)
Model 1
a 1.21 (0.85–1.72) 1.80 (0.66–4.85) 1.75 (1.12–2.75)
Model 2
b 1.24 (0.87–1.78) 2.10 (0.77–5.77) 1.88 (1.19–2.96)
Model 3
c 1.25 (0.84–1.86) 2.27 (0.82–6.31) 1.79 (1.10–2.91)
Model 4
d 1.24 (0.83–1.86) 2.18 (0.79–6.07) 1.85 (1.14–3.00)
Model 5
e 1.32 (0.89–1.96) 2.11 (0.75–5.94) 1.80 (1.11–2.93)
Model 6
f 1.21 (0.79–1.86) 2.52 (0.70–9.03) 1.61 (0.94–2.78)
a Model 1 = Age
b Model 2 = Model 1 ? gender, ethnicity, prior smoking
c Model 3 = Model 2 ? history of congestive heart failure, diastolic dysfunction
d Model 4 = Model 3 ? left ventricular ejection fraction
e Model 5 = Model 3 ? wall motion score
f Model 6 = Model 5 ? inducible ischemia
Fig. 2 Kaplan–Meier survival
curves showing freedom from
cardiovascular events
(p = 0.006 from log rank test)
364 Clin Res Cardiol (2011) 100:359–366
123the anterior myocardial wall compared with the inferior or
lateral walls. Importantly, we cannot exclude an associa-
tion of inferior territories with adverse outcomes, as the
magnitudes of this association reported in Table 4 were in
fact greater for inferior territories than anterior territories.
However, the small number of inferior Q waves noted in
the study population contributed to very wide conﬁdence
intervals and precludes a reliable conclusion about the
differential impact of Q waves across territories.
The strengths of the current study include a large sample
size, virtually complete outcome ascertainment, and
adjustment for multiple variables including baseline char-
acteristics and echocardiographic parameters. However,
there are several important limitations that should also be
considered in the evaluation of our ﬁndings. First, although
the total sample was sizeable, the sample sizes for analysis
of each Q wave territory were much smaller, particularly
for inferior and lateral territories. Second, the high pro-
portion of male participants in the study population limits
generalizability to women. Third, patients with Q waves in
multiple territories were not analyzed separately. Some
data suggest that patients with lateral Q waves in addition
to anterior Q waves may be at greater risk for left ven-
tricular thrombus formation than those with anterior Q
waves alone [26]. Fourth, survival bias inherent in the
study of unrecognized infarction may have weakened the
associations we report. Finally, we did not perform cardiac
MRI to determine the presence of non-Q-wave unrecog-
nized MI or conﬁrm the presence of myocardial scar in
patients with Q waves. Unrecognized Q-wave infarction
may account for only a fraction of all clinically signiﬁcant
unrecognized MI [21], and estimates of the speciﬁcity of Q
waves for infarction have ranged from 20 to 100% [11, 21,
22]. Nevertheless, the importance of this study is that even
without the use of more advanced technologies, important
prognostic information can be obtained from a simple
ECG.
In conclusion, in a cohort of patients with stable CAD
but without prior history of MI, we demonstrated that the
prevalence of unrecognized infarction is comparable to the
prevalence in the general population. We further observed
that the detection of Q waves, in any lead or anterior leads
alone, on routine ECG predicts adverse cardiovascular
outcomes independently of established risk factors, medi-
cal history, and echocardiographic parameters of global
systolic and diastolic function. Finally, this association
may act in part through inducible segmental wall
dysfunction.
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